efficacy of acupuncture on symptoms of htlv1 patients

Study of the efficacy of acupuncture in the control of patients’ symptoms with HTLV1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP(

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016031327036N1

Enrollment

Registered

2017-05-05

Start date

2015-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: HTLV1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Condition 2: HTLV1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Tropical spastic paraplegia Retrovirus infections, not elsewhere classified

Interventions

Intervention: In this study, the intervention is semi-experimental with pretest and posttest measure design. The patients will be neurologically examined in clinic and their peripheral blood samples

Rehabilitation

Intervention: In this study, the intervention is semi-experimental with pretest and posttest measure design. The patients will be neurologically examined in clinic and their peripheral blood samples

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Informed consent, and confirmation of HAM / TSP according to World Health Organization (WHO) criteria Exclusion criteria: Patients who have contraindications for acupuncture such as wound or skin infection at the time of acupuncture therapy or bleeding diathesis; patients who suffer from other illness that may exacerbate the paraparesis such as vitamin B12 deficiency. The intervention is acupuncture.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Spastic Paraparasy. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion ashworth.;Incontinency. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion ICIQ-SF.;Back pain. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion VAS.;Disability. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion OMDS.;Viral load. Timepoint: Before the intervention After the intervention, three months after the intervention. Method of measurement: DNA copy number of virus per mononuclear cells.	—

Measure

Time frame

Spastic Paraparasy. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion ashworth.;Incontinency. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion ICIQ-SF.;Back pain. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion VAS.;Disability. Timepoint: Before the intervention and After the intervention then three months after the intervention. Method of measurement: on basis of Criterion OMDS.;Viral load. Timepoint: Before the intervention After the intervention, three months after the intervention. Method of measurement: DNA copy number of virus per mononuclear cells.

—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Amirali Ghahremani

Mashahd university of medical

ghahremaniaa921@mums.ac.ir? shoeibia@gmail.com+98 51 38049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026